Caira Surgical to Present their Radar Surgical Tracking Technologies for Joint Replacement Surgery at LSI USA ’23 Emerging Medtech Summit

Firm meeting with prospective investors and strategics to finalize $ten million Series A funding round

DANA POINT, Calif., March 16, 2023 (GLOBE NEWSWIRE) — Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced right now that Jon Greenwald, Chief Executive Officer, will present at the fourth annual Life Science Intelligence (LSI) USA ’23 Emerging Medtech Summit on March 22, 2023, at 11:30 a.m. PT (Track 1) in Dana Point, California.

The presentation will highlight Caira’s mission to make sophisticated orthopedic technologies much more accessible to surgeons, individuals, ambulatory surgery centers (ASCs) and hospitals worldwide by eliminating the adoption barriers inherent in current technologies with the aim of disrupting the $13 billion joint replacement market place with Caira’s superior, proprietary technologies. The organization will also introduce investors and strategics to its initial item – the Caira Radar Navigation Program for Total Knee Replacement (TKR). TKR is the biggest joint replacement segment by procedural volume, as effectively as the segment with the highest price of patient dissatisfaction and the highest revision burden.

The Caira TKA Radar Navigation Program is the initial sub-millimeter correct radar tracking technique for orthopedic surgery and provides important improvements more than the higher-price, huge-footprint and invasive surgical hardware supplied by incumbent surgical navigation and robotic systems. Employing sophisticated radar surgical tracking and rapid landmark registration, the Caira technique seamlessly integrates into surgeons’ workflow, enhancing accuracy, efficiency and repeatability when simultaneously decreasing price, complexity and several of the dangers linked with legacy technologies.

“Orthopedic surgeons need to have sophisticated technologies that are aligned with the price, efficiency and patient outcome demands of the quickly expanding worldwide joint replacement market place,” mentioned Caira Co-Founder Morteza Meftah, M.D., Associate Professor of Orthopaedic Surgery at NYU Langone Healthcare Center and President of the International Society for Technologies in Arthroplasty. “I think the Caira TKA Radar Navigation Program will absolutely modify the paradigm of navigation and robotics in arthroplasty – supplying a much better alternative for surgeons, hospitals, and ASCs worldwide when also enhancing patient outcomes.”

By supplying a minimally invasive and price-effective answer, Caira Surgical’s technologies is a meaningful improvement to aid overcome the obstacles that have prevented the broad market place adoption of incumbent robotic and navigation systems. At present, these sophisticated technologies are only utilised in significantly less than 20% of TKA procedures due to their inherent disadvantages which includes the high-priced capital gear and per-surgery disposables, complicated workflows and improved process occasions, added incisions and invasive surgical hardware that can enhance post-operative discomfort and complications.

“The Caira TKA Radar Navigation Program addresses every of these shortcomings to genuinely revolutionize orthopedic surgery,” mentioned Caira Surgical Chief Executive Officer Jon Greenwald. “It was created to address the frustrations we’ve been hearing from surgeons, hospitals and ASCs given that surgical navigation and robotic technologies have been initial introduced in the 1990s, which includes workflow, complexity, invasiveness and price.”

Caira Surgical is presently raising a $ten million Series A Funding Round. Series A funding will be utilised to drive continued item improvement and R&ampD and assistance a restricted industrial release of the Caira TKA Radar Navigation Program in 2024. These attending the Emerging Medtech Summit who are interested in scheduling a one particular-on-one particular meeting with Caira Surgical senior leadership can do so by emailing ir@cairasurgical.com.

LSI USA ’23 is the market-major medtech investment and partnering occasion featuring much more than 250 innovators presenting to much more than 1,000 leading investors and strategics. The occasion will take spot March 20 – 23, 2023 at the Waldorf Astoria Monarch Beach Resort &amp Club in Dana Point, Calif. Caira Surgical will present as portion of Track 1 on Wednesday, March 22 from 11:30 – 11:39 a.m. PT. For much more facts, check out https://www.lifesciencemarketresearch.com/medtech-summit-2023.

About Caira Surgical
Caira is revolutionizing the usability, economics, security, and accessibility of sophisticated surgical navigation and robotics for orthopedic surgery. The company’s initial item is a navigation technique for total knee replacement. Employing Caira’s sophisticated, proprietary sub-millimeter correct Radar Surgical Tracking technologies, Caira Surgical Navigation eliminates line-of-sight interference, invasive surgical instruments, and a number of incisions inherent in current surgical tracking systems. Caira’s technologies enables a basic workflow and drastically reduces the price and complexity of using sophisticated technologies in joint replacement surgery. The organization focuses on creating technologies that overcomes adoption barriers to make sophisticated technologies much more accessible to surgeons, individuals, hospitals, and ambulatory surgery centers (ASCs) worldwide. For much more facts, please check out cairasurgical.com.